Business Context and Reporting Period
This Form 8-K filing by LeMaitre Vascular, Inc. (Delaware) reports on events occurring on June 4, 2015, specifically the company's 2015 Annual Meeting of Stockholders. The report details corporate governance actions, including the election of directors and the approval of an amended equity incentive plan.
Key Financial Metrics
This filing is a current report regarding corporate governance and does not contain financial performance data. The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The primary material change reported is the approval of the Third Amended and Restated 2006 Stock Option and Incentive Plan. This amendment increases the aggregate number of shares authorized for issuance under the plan by 2,500,000 shares, bringing the total to 5,500,000 shares, plus shares from expired or cancelled options under prior plans.
Outlook, Risks, and Management Commentary
Management commentary is limited to the procedural outcomes of the Annual Meeting. The stockholders ratified the appointment of Grant Thornton LLP as the independent registered public accounting firm for the year ending December 31, 2015. No specific forward-looking guidance, risk factors, or unusual items were disclosed in this specific filing.
Stockholder Vote Results
- Proposal 1 (Election of Directors): Lawrence J. Jasinski, Cornelia W. LeMaitre, and John J. O'Connor were elected as Class III directors for three-year terms.
- Proposal 2 (Amended Stock Plan): Approved with 7,782,509 shares for and 3,503,626 shares against.
- Proposal 3 (Auditor Ratification): Grant Thornton LLP was ratified with 13,723,269 shares for and 2,863 shares against.
Key Facts for Investor Verification
- Verify the dilution impact of the newly authorized 2,500,000 shares under the amended stock option plan.
- Confirm the terms of the Third Amended and Restated 2006 Stock Option and Incentive Plan referenced in Exhibit 10.1.
- Note the significant vote against the stock plan amendment (approximately 31% of votes cast were against).
- Review the full proxy statement filed on April 24, 2015, for detailed summaries of the plan and director nominees.